Author(s):
Mansi Shah, Dipti Patel
Email(s):
dipti.patel@paruluniversity.ac.in
DOI:
10.5958/0974-360X.2020.01083.5 
Address:
Mansi Shah1, Dipti Patel2*
1PhD Scholar, Parul Institute of Pharmacy and Research, Parul University, Vadodara.
2HOD Department of Pharmaceutics, Parul Institute of Pharmacy and Research, Parul University, Vadodara.
*Corresponding Author
Published In:
Volume - 13,
Issue - 12,
Year - 2020
ABSTRACT:
Tadalafil has low solubility and low oral bioavailability, so it’s a challenge to formulate suitable dosage form. In this Present investigation to enhance the dissolution rate and solubility skimmed milk is used as a carrier. Physical mixers were prepared using various drugs to carrier ratio. Material and Methods: Spry drying technology was used to prepared solid dispersion of drug with skimmed milk. Various techniques were used to characterize the solid dispersion immediately after they were made which includes Differential scanning calorimetry, fourier transform infrared spectroscopy, X-ray diffraction and in-vitro dissolution profiles. Results: The Differential Scanning Calorimetry thermograms of raw drug indicated of its anhydrous crystalline nature. In thermograms of solid dispersion, the characteristic peak was absent suggesting the change from crystalline nature to amorphous form. X-ray diffraction confirmed the results. The results of raw drug showed highly extreme peak characteristic of its crystalline nature where solid dispersion showed less intense, more diffused peak indicating the change in crystalline form. Fourier transform infrared spectroscopy studies indicated between drug and carrier there were no interaction. The whole formulation showed distinct enhancement in the drug release behavior and solubility. Conclusion: The optimum drug to carrier ratio 1:10 enhance the solubility and in-vitro drug release also increase by 3 fold. For improvement of drug release and solubility, it was concluded that as a carrier skimmed milk powder can be utilized very well.
Cite this article:
Mansi Shah, Dipti Patel. Development and Characterization of tadalafil solid dispersion using skimmed milk for improved the solubility and Dissolution release profile. Research J. Pharm. and Tech. 2020; 13(12):6212-6217. doi: 10.5958/0974-360X.2020.01083.5
Cite(Electronic):
Mansi Shah, Dipti Patel. Development and Characterization of tadalafil solid dispersion using skimmed milk for improved the solubility and Dissolution release profile. Research J. Pharm. and Tech. 2020; 13(12):6212-6217. doi: 10.5958/0974-360X.2020.01083.5 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-12-98
REFERENCES:
1. Di L, Paul V and Takashi M. Bridging solubility between drug discovery and development. Drug Discov Today. 2012; 17(9-10): 486-495.
2. Wlodarski K, Sawicki W, Paluch KJ, Tajber L, Grembecka M, Hawelek L, Wojnarowska Z, Grzybowska K, Talik E and Paluch M. The influence of amorphization methods on the apparent solubility and dissolution rate of Tadalafil. Eur. J. Pharm. Sci. 2014; 62: 132–140.
3. Kawabata Y, Wada K, Nakatani M, Yamada S and Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 2011; 420: 1–10.
4. Jin T. Solid dosage forms for rapid dissolution of poorly soluble drugs. US Patent 20040001888.
5. Leuner C and Dressman J. Improving drug solubility for oral delivery using solid dispersion. Eur J Pharm Biopharm. 2000; 50: 47–60.
6. Smikalla MM and Urbanetz NA. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol. Eur J Pharm Biopharm. 2006; 66: 106–12.
7. Choudhary A, Aggarwal G, Zakir F and Kumar V. Mini review: journey of solid dispersion technique from bench to scale. Int Res J Pharm. 2011; 2: 46-51.
8. Asare-Addo K, Supuk E and Al-Hamidi H. Triboelectrification and dissolution property enhancements of solid dispersions. Int J Pharm. 2015; 485: 306–16.
9. Sekiguchi K and Obi N. Studies on absorption of eutectic mixtures, I. A comparison of behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem Pharm Bull. 1961; 9: 866-872.
10. Chiou WL and Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971; 60: 1281–302.
11. Tsertsvadze A, Fink HA, Yazdi F, Ansari MT, Sampson M, Fox S, Moher D and Wilt TJ. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009; 151(9): 650–661.
12. Thulluru A, Kumar K, Chandana P, Maunika R and Munichandra K. Formulation and evaluation of Tadalafil oral disintegrating tablets with enhanced dissolution rate by complexation. Int J Res Dev Pharm Sci. 2016; 6(3): 2631-2640.
13. Mahmoud El-B, Nazrul H, Gihan F and Faiyaz S. Solubility and Dissolution Enhancement of Tadalafil Using Self-Nanoemulsifying Drug Delivery System. J. Oleo Sci. 2014: 63(6): 567-576.
14. Wlodarski K, Tajber L and Sawicki W. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA. Eur J Pharm Biopharm. 2016; 109: 14–23.
15. Sisodiya M and Saudagar R. Solubility enhancement, formulation development and evaluation of immediate release tablet of antihypertensive drug tadalafil. JDDT. 2018; 8(5): 294-302.
16. Park J, Cho W, Kang H, Lee B, Kim TS and Hwang SJ. Effect of operating parameters on PVP/tadalafil solid dispersions prepared using supercritical anti-solvent process. J Supercrit Fluids. 2014; 90: 126-133.
17. Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L and TajberL. Physicochemical properties of tadalafil solid dispersions-Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Eur. J. Pharm. Biopharm. 2015; 94: 106-115.
18. Dickinson E and Stainsby G. Advances in Food Emulsion and Foams. Elsevier Applied Scienees. London 1988:397.
19. Sahin NO and Arslan H. Inclusion complex of prednisolone with skimmed milk. Part I: physicochemical characterization. 2007; 127(8); 1255-1261.
20. Topaloğlu Y, Yener G and Gönüllü U. Inclusion of ketoprofen with skimmed milk by freeze-drying, Il Farmaco. 1999; 54(10): 648–652.
21. Aslı ZB, Dilara T, Mehmet K, and Figen KE. Spray dried melon seed milk powder: physical, rheological and sensory Properties. J Food Sci Technol. 2016; 53(5): 2396–2404.
22. Lu M, Xing H, Yang Z and Ding P. Dissolution enhancement of tadalafil by liquisolid technique. Pharma Dev Tech. 2016; 10(5): 1-13.
23. Hecq J, Deleers M, Fanara D, Vranckx H and Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm. 2005; 299(1-2): 167–177.
24. Shinde S, Shaikh F, and Gawande A. Solubility enhancement and physicochemical characterization of tadalafil by inclusion complexation method. WJPPS. 2018; 7(8): 687-706.
25. Yuichi T, Atsutoshi I, Hiiroko S, Toshio O and Keiji Y. Characterization and quantitation of Clarithromycin polymorphs by powder X-Ray diffractometry and solid state NMR spectroscopy. Chem. Pharm. Bull.2002; 50(8): 1128-1130.
26. Philippsen FRZ, Falcao BR, Teixeira LM and Sausen TR. Development and validation of a dissolution method for a BCS class IV drug – tadalafil. IJAPA. 2017; 07(02): 10-15.
27. Wlodarski K, Sawicki W, Paluch KJ, Tajber L, Grembecka M, Hawelek L, Wojnarowska Z, Grzybowska K, Talik E and PaluchM. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil. Eur. J. Pharm. Sci. 2014; 62: 132–140.
28. Kumar SG and Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi. 2006; 126(2): 93-97.
29. Choudhary A, Rana AC, Aggarwal G, Kumar V and ZakirF. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B. 2012; 2(4): 421-428.